Diego Flichman

2.2k total citations
71 papers, 1.5k citations indexed

About

Diego Flichman is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Diego Flichman has authored 71 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Epidemiology, 53 papers in Hepatology and 15 papers in Infectious Diseases. Recurrent topics in Diego Flichman's work include Hepatitis B Virus Studies (50 papers), Hepatitis C virus research (50 papers) and Liver Disease Diagnosis and Treatment (25 papers). Diego Flichman is often cited by papers focused on Hepatitis B Virus Studies (50 papers), Hepatitis C virus research (50 papers) and Liver Disease Diagnosis and Treatment (25 papers). Diego Flichman collaborates with scholars based in Argentina, United States and Italy. Diego Flichman's co-authors include Carlos J. Pirola, Gustavo Castaño, Julio San Martino, Silvia Sookoian, Tomas Fernández Gianotti, María Mora González López Ledesma, Silvia Sookoian, Arun J. Sanyal, F. Mirshahi and Rodolfo Campos and has published in prestigious journals such as PLoS ONE, American Journal of Clinical Nutrition and Gut.

In The Last Decade

Diego Flichman

69 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Diego Flichman Argentina 18 1.1k 600 391 325 275 71 1.5k
Amon Asgharpour United States 16 719 0.6× 372 0.6× 315 0.8× 128 0.4× 244 0.9× 39 1.4k
Vikas Verma India 17 855 0.8× 519 0.9× 831 2.1× 448 1.4× 145 0.5× 47 1.8k
Ali Mencin United States 10 687 0.6× 317 0.5× 641 1.6× 131 0.4× 181 0.7× 22 1.4k
Ming‐Ling Chang Taiwan 22 1.2k 1.1× 1.1k 1.9× 302 0.8× 157 0.5× 80 0.3× 121 1.9k
Tetsuro Shimakami Japan 25 798 0.7× 906 1.5× 999 2.6× 578 1.8× 48 0.2× 89 2.0k
Rosmawati Mohamed Malaysia 21 1.7k 1.5× 1.4k 2.3× 136 0.3× 62 0.2× 279 1.0× 63 2.0k
Yedidya Saiman United States 14 767 0.7× 798 1.3× 282 0.7× 84 0.3× 73 0.3× 22 1.4k
Hikmet Akkız Türkiye 23 443 0.4× 305 0.5× 505 1.3× 340 1.0× 58 0.2× 73 1.4k
Richard Kirsch South Africa 9 754 0.7× 196 0.3× 391 1.0× 48 0.1× 232 0.8× 14 1.5k
Michiari Okuda Japan 15 1.2k 1.1× 1.2k 2.1× 355 0.9× 82 0.3× 48 0.2× 28 1.9k

Countries citing papers authored by Diego Flichman

Since Specialization
Citations

This map shows the geographic impact of Diego Flichman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diego Flichman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diego Flichman more than expected).

Fields of papers citing papers by Diego Flichman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diego Flichman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diego Flichman. The network helps show where Diego Flichman may publish in the future.

Co-authorship network of co-authors of Diego Flichman

This figure shows the co-authorship network connecting the top 25 collaborators of Diego Flichman. A scholar is included among the top collaborators of Diego Flichman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diego Flichman. Diego Flichman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Elizalde, María Mercedes, et al.. (2025). Contrasting Effect of Curcumin on Hepatitis B Virus Replication According to the Hepatoma Cell Line. Pathogens. 14(2). 203–203. 1 indexed citations
2.
Lello, Federico A. Di, Alfredo P. Martínez, & Diego Flichman. (2022). Insights into induction of the immune response by the hepatitis B vaccine. World Journal of Gastroenterology. 28(31). 4249–4262. 26 indexed citations
3.
Elizalde, María Mercedes, et al.. (2021). Biological Characterization of Hepatitis B virus Genotypes: Their Role in Viral Replication and Antigen Expression. Frontiers in Microbiology. 12. 758613–758613. 18 indexed citations
4.
Pisano, María Belén, et al.. (2021). Viral hepatitis update: Progress and perspectives. World Journal of Gastroenterology. 27(26). 4018–4044. 56 indexed citations
5.
Martínez, Alfredo P., et al.. (2020). Seroprevalence of hepatitis B, hepatitis C and HIV infection among patients undergoing haemodialysis in Buenos Aires, Argentina. Journal of Medical Microbiology. 70(1). 2 indexed citations
6.
Lello, Federico A. Di, Claudio Galli, Sandra Gallego, et al.. (2020). Hepatitis B surface antibodies seroprevalence among people born before and after implementation of universal HBV vaccination. Vaccine. 38(12). 2678–2682. 5 indexed citations
7.
Elizalde, María Mercedes, Ina Sevic, Daniel Grasso, et al.. (2018). HBV subgenotypes F1b and F4 replication induces an incomplete autophagic process in hepatocytes: Role of BCP and preCore mutations. PLoS ONE. 13(5). e0197109–e0197109. 4 indexed citations
8.
Pirola, Carlos J., Martín Garaycoechea, Diego Flichman, et al.. (2018). Splice variant rs72613567 prevents worst histologic outcomes in patients with nonalcoholic fatty liver disease. Journal of Lipid Research. 60(1). 176–185. 104 indexed citations
9.
Sookoian, Silvia, Diego Flichman, Martín Garaycoechea, et al.. (2018). Lack of evidence supporting a role of TMC4-rs641738 missense variant—MBOAT7- intergenic downstream variant—in the Susceptibility to Nonalcoholic Fatty Liver Disease. Scientific Reports. 8(1). 5097–5097. 46 indexed citations
10.
11.
Sevic, Ina, María Mora González López Ledesma, Diego Flichman, & Rodolfo Campos. (2017). HBV DNA genome co-transfection procedure for the evaluation of relative fitness. PLoS ONE. 12(5). e0175543–e0175543. 5 indexed citations
12.
Torres, Carolina, Ina Sevic, Inés Badano, et al.. (2016). Molecular epidemiology of hepatitis B virus in Misiones, Argentina. Infection Genetics and Evolution. 44. 34–42. 14 indexed citations
13.
Sookoian, Silvia, Gustavo Castaño, Romina Scian, et al.. (2016). Serum aminotransferases in nonalcoholic fatty liver disease are a signature of liver metabolic perturbations at the amino acid and Krebs cycle level. American Journal of Clinical Nutrition. 103(2). 422–434. 90 indexed citations
14.
Torres, Carolina, et al.. (2015). Identification of a new clade of hepatitis B virus genotype F. Infection Genetics and Evolution. 34. 122–125. 3 indexed citations
15.
Flichman, Diego, et al.. (2014). Prevalence and trends of markers of hepatitis B virus, hepatitis C virus and human Immunodeficiency virus in Argentine blood donors. BMC Infectious Diseases. 14(1). 218–218. 35 indexed citations
16.
Caputo, Mariela, Viviana Ré, Félix Núñez, et al.. (2014). Distribution of genetic polymorphisms associated with hepatitis C virus (HCV) antiviral response in a multiethnic and admixed population. The Pharmacogenomics Journal. 14(6). 549–554. 9 indexed citations
17.
Torres, Carolina, et al.. (2013). Influence of overlapping genes on the evolution of human hepatitis B virus. Virology. 441(1). 40–48. 22 indexed citations
18.
Ledesma, María Mora González López, Omar Galdame, Hugo Fainboim, et al.. (2011). Characterization of the basal core promoter and precore regions in anti-HBe-positive inactive carriers of hepatitis B virus. International Journal of Infectious Diseases. 15(5). e314–e320. 17 indexed citations
19.
Muñoz, Alberto, David Levi, A Podestà, et al.. (2000). Interferon-α 2b combined with daily ketoprofen administration improves virological response in chronic hepatitis C: a prospective and randomised trial. Gut. 46(3). 427–431. 14 indexed citations
20.
Flichman, Diego, P. Colombatto, A. Randone, et al.. (1997). Quantitative detection of hepatitis C virus RNA in the serum of patients with chronic hepatitis C treated with interferon: A pilot study. Clinical and Diagnostic Virology. 8(1). 63–70. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amon Asgharpour Breakdown of academic impact, for papers by Vikas Verma Breakdown of academic impact, for papers by Ali Mencin Breakdown of academic impact, for papers by Ming‐Ling Chang Breakdown of academic impact, for papers by Tetsuro Shimakami Breakdown of academic impact, for papers by Rosmawati Mohamed Breakdown of academic impact, for papers by Yedidya Saiman Breakdown of academic impact, for papers by Hikmet Akkız Breakdown of academic impact, for papers by Richard Kirsch Breakdown of academic impact, for papers by Michiari Okuda
Rankless by CCL
2026